For more than 90 years, WAB-GROUP, the renowned manufacturer of wet milling technology has stood for high quality and reliability. A worldwide sales and service network, enables us to fully support our clients, from process validation to qualification. The DYNO®-MILL brand in pharmaceutical applications is designed for API processing and cell disruption.
Wet milling of APIs in sterile production is no issue for the WAB Group process technology. The comminution, grinding and dispersion of active pharmaceutical ingredients in a liquid environment are important process steps in pharmaceutical formulation development. These steps serve to increase the solubility of the active ingredients, ensure the homogeneity of the formulation and ultimately improve the efficacy and bioavailability of the drug.
Proper mixing and homogenization of APIs is critical to ensure the efficacy, safety and quality of the final products. This is ensured by means of our TURBULA® three-dimensional shaker mixers. The production of individual APIs in a continuous process using our WAB IMPA°CT REACTOR opens up new possibilities. Reactions can now be carried out in combination with solid, liquid and gaseous reactants.
Flow Chemistry enables a continuous product flow and a residence time tailored to the product within the WAB IMPA°CT REACTOR. Excellent surface renewal enables particularly efficient activation of reactants and catalysts, which in turn reduces overall energy requirements. Due to the increased efficiency of the reaction, the use of solvents can be reduced or even eliminated.